Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN)

Conditions:   Gestational Trophoblastic Neoplasia;   Choriocarcinoma;   Placental Site Trophoblastic Tumor;   Epithelioid Trophoblastic TumorInterventions:   Drug: TRC105;   Drug: BevacizumabSponsor:   Tracon Pharmaceuticals Inc.Not yet recruiting - verified January 2016

Source: ClinicalTrials.gov - January 20, 2016 Category: Research Source Type: clinical trials